Intranasal live-attenuated influenza vaccine (LAIV) is unlikely to cause egg-mediated allergic reactions in egg-allergic children

Paul J. Turner; Michel Erlewyn-Lajeunesse

doi:10.1016/j.jaip.2014.11.017

Intranasal live-attenuated influenza vaccine (LAIV) is unlikely to cause egg-mediated allergic reactions in egg-allergic children

Paul J. Turner^*, Michel Erlewyn-Lajeunesse

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	312-313
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	3
Issue number	2
DOIs	https://doi.org/10.1016/j.jaip.2014.11.017
Publication status	Published - 1 Mar 2015

Bibliographical note

Funding Information:
This report is independent research commissioned and funded by the Department of Health Policy Research Programme (National Vaccine Evaluation Consortium, 039/0031). The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health.

Funding Information:
P. J. Turner is in receipt of a Clinician Scientist award funded by the UK Medical Research Council (Grant reference MR/K010468/1) and has received research support from the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Imperial College London Healthcare NHS Trust.

Funding Information:
Conflicts of interest: P. J. Turner has received research support from the Department of Health , NHS National Institute for Health Research , and UK Medical Research Council . M. Erlewyn-Lajeunesse has received support for attendance at scientific meetings from Allergy Therapeutics , ALK Albelo , MEDA Pharmaceuticals , and Thermo Fisher .

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaip.2014.11.017

Cite this

@article{121b81bd969b4dbcb503883c16a78ff2,

title = "Intranasal live-attenuated influenza vaccine (LAIV) is unlikely to cause egg-mediated allergic reactions in egg-allergic children",

author = "Turner, {Paul J.} and Michel Erlewyn-Lajeunesse",

note = "Funding Information: This report is independent research commissioned and funded by the Department of Health Policy Research Programme (National Vaccine Evaluation Consortium, 039/0031). The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health. Funding Information: P. J. Turner is in receipt of a Clinician Scientist award funded by the UK Medical Research Council (Grant reference MR/K010468/1) and has received research support from the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Imperial College London Healthcare NHS Trust. Funding Information: Conflicts of interest: P. J. Turner has received research support from the Department of Health , NHS National Institute for Health Research , and UK Medical Research Council . M. Erlewyn-Lajeunesse has received support for attendance at scientific meetings from Allergy Therapeutics , ALK Albelo , MEDA Pharmaceuticals , and Thermo Fisher . ",

year = "2015",

month = mar,

day = "1",

doi = "10.1016/j.jaip.2014.11.017",

language = "English",

volume = "3",

pages = "312--313",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Intranasal live-attenuated influenza vaccine (LAIV) is unlikely to cause egg-mediated allergic reactions in egg-allergic children

AU - Turner, Paul J.

AU - Erlewyn-Lajeunesse, Michel

N1 - Funding Information: This report is independent research commissioned and funded by the Department of Health Policy Research Programme (National Vaccine Evaluation Consortium, 039/0031). The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health. Funding Information: P. J. Turner is in receipt of a Clinician Scientist award funded by the UK Medical Research Council (Grant reference MR/K010468/1) and has received research support from the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Imperial College London Healthcare NHS Trust. Funding Information: Conflicts of interest: P. J. Turner has received research support from the Department of Health , NHS National Institute for Health Research , and UK Medical Research Council . M. Erlewyn-Lajeunesse has received support for attendance at scientific meetings from Allergy Therapeutics , ALK Albelo , MEDA Pharmaceuticals , and Thermo Fisher .

PY - 2015/3/1

Y1 - 2015/3/1

UR - http://www.scopus.com/inward/record.url?scp=84924146404&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2014.11.017

DO - 10.1016/j.jaip.2014.11.017

M3 - Letter

C2 - 25754723

AN - SCOPUS:84924146404

SN - 2213-2198

VL - 3

SP - 312

EP - 313

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 2

ER -

Intranasal live-attenuated influenza vaccine (LAIV) is unlikely to cause egg-mediated allergic reactions in egg-allergic children

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this